MedTrace Logo

A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema Patients

NCT01714245 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2019-09-25

No results posted yet for this study

Summary

The purpose of this study is to determine if CLn BodyWash, a novel new gel cleanser formulated with surfactants and preserved with sodium hypochlorite, is effective at decreasing severity, body surface area and itching for patients with Atopic Dermatitis, or eczema.

Conditions

Sponsors & Collaborators

  • TopMD Skin Care, Inc.

    lead INDUSTRY

Principal Investigators

  • Adelaide A. Hebert, MD · University of Texas Medical School - Houston

Eligibility

Min Age
6 Months
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01714245 on ClinicalTrials.gov